Charming Medical Limited
MCTA
$29.36
$1.866.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 81.01% | 81.01% | 25.21% | 25.21% | |
| Total Depreciation and Amortization | -46.63% | -46.63% | -17.89% | -17.89% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 102.56% | 102.56% | 50.00% | 50.00% | |
| Change in Net Operating Assets | -4.02% | -4.02% | -122.43% | -122.43% | |
| Cash from Operations | 163.36% | 163.36% | -24.93% | -24.93% | |
| Capital Expenditure | -2,447.83% | -2,447.83% | 17.38% | 17.38% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -44,665.22% | -44,665.22% | 17.38% | 17.38% | |
| Total Debt Issued | 449.12% | 449.12% | 19.01% | 19.01% | |
| Total Debt Repaid | -28.88% | -28.88% | 22.77% | 22.77% | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -95.03% | -95.03% | 141.43% | 141.43% | |
| Cash from Financing | -92.30% | -92.30% | 143.48% | 143.48% | |
| Foreign Exchange rate Adjustments | 121.43% | 121.43% | -167.57% | -167.57% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -302.51% | -302.51% | 178.29% | 178.29% | |